共 50 条
- [31] Investigating downstream processing options for monoclonal antibody manufacture [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
- [32] MEDI 52-Development of 5HT2A antagonists based on the aporphine alkaloid nantenine [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
- [33] Development of a downstream purification process for an early phase bispecific antibody: A case study [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
- [35] BIOT 211-Evaluation and removal of key plant-derived impurities during downstream process development [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
- [36] A workflow for the development of template-assisted membrane crystallization downstream processing for monoclonal antibody purification [J]. Nature Protocols, 2023, 18 : 2998 - 3049
- [39] BIOT 9-A predictive probability approach for establishing design space in a CHO-based monoclonal antibody process [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
- [40] Applications of high throughput screening in the process development for monoclonal antibody purification [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253